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Competition by @-adrenergic agonists and antago- 
nists for ‘2SI-pindolol binding sites on intact cells 
(1321N1 human astrocytoma and C62B rat glioma) 
was measured using short time binding assays as  pre- 
viously described (Toews, M. L., Harden, T. K., and 
Perkins, J. P. (1983) Proc. Natl. Acad.  Sei. U. S. A. 
80, 3553-3557).  Preincubation of cells with agonists 
converted about half of the cellular @-adrenergic  re- 
ceptors from a form exhibiting high affinity  for  the 
agonists isoproterenol and  epinephrine  and  the  antag- 
onist sotalol to a form  exhibiting much lower apparent 
affinity  for these ligands  in  short time assays. Expo- 
sure to agonists did not alter  the affinity of receptors 
for  the  antagonist metoprolol. This  change in the ligand 
binding properties of the receptor was rapid (t l lz  = 1- 
2 min following a  lag of about 0.5 min), reversible (tllz 
= 6-8 min), and dependent on the agonist concentra- 
tion present during the preincubation = 15 nM for 
isoproterenol). Both isoproterenol and sotalol attained 
equilibrium with  the high affinity  receptors  very  rap- 
idly but  equilibrated only slowly with those receptors 
exhibiting low apparent  affinity  in  short time assays. 
These results are  interpreted in  terms of a model  which 
postulates that both the low apparent  affinity in short 
time assays and  the subsequent slow equilibration of 
hydrophilic ligands  with these receptors  result from 
agonist-induced internalization of a fraction of cell 
surface  @-adrenergic receptors. The relationship of this 
change in receptor binding properties to other aspects 
of agonist-induced desensitization of the  @-adrenergic 
receptor-coupled adenylate cyclase system is dis- 
cussed. 
The phenomenon of desensitization of receptor-mediated 
hormone responses upon prolonged incubation  in the presence 
of hormone is well documented (2-4). In the case of @- 
adrenergic receptors, incubation of cells in  the presence of 
agonists has been shown to lead to dramatic changes in  both 
the physical and pharmacological properties of these receptors 
measured subsequently  in  membrane  preparations (2-4). Re- 
cently developed methodology has made it feasible to study 
@-adrenergic receptors  on intact cells as well as in membrane 
preparations (5-8). We have been studying lZ5I-PIN’ binding 
to P-adrenergic receptors on intact cells (1) as part of a 
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continuing investigation of the changes that occur in @-adre- 
nergic receptors during the process of agonist-induced desen- 
sitization. 
In a previous manuscript (1) we measured binding of lZ5I- 
PIN to intact cells in short time assays under conditions 
approximating the initial velocity of binding of the radioli- 
gand. The results clearly demonstrated that in  both 1321N1 
human astrocytoma cells and C62B rat glioma cells the native 
state of the 0-adrenergic receptor was predominantly one with 
high affinity  for agonists. A small fraction of ‘“I-PIN binding 
sites exhibited very low apparent affinity’ for agonists under 
these conditions. As in previous studies (5-8), only low affinity 
binding was observed in longer time equilibrium binding 
assays. In contrast, the observed affinity of intact cell recep- 
tors for antagonists was the same when measured in equilib- 
rium assays as when measured in short time assays. These 
results, like those of Pittman  and Molinoff (8), suggested that 
an agonist-induced change in agonist binding properties of 
the receptor was occurring in these cells. In  the experiments 
reported here we have further used the short time assay 
approach to investigate changes in the ligand binding prop- 
erties of intact cell @-adrenergic receptors that occur during 
incubation in  the presence of agonists. A discussion of the 
possible relationship of these changes to  the various other 
aspects of the phenomenon of desensitization also is pre- 
sented. 
EXPERIMENTAL PROCEDURES 
Materials-(-)-Isoproterenol bitartrate, (-)-epinephrine bitar- 
trate,  and (&)-propranolol hydrochloride were obtained from Sigma. 
[3H]Adenine and [1z51]sodium iodide were obtained from ICN and 
Amersbam Corp., respectively. The following drugs were generous 
gifts: (-)-pindolo1 from Sandoz Pharmaceuticals, (&)-sotalol hydro- 
chloride and soterenol hydrochloride from Bristol-Myers Co., and 
(+)-metoprolo1 and terbutaline  sulfate from Drs. P. B. Molinoff and 
B. B. Wolfe (Department of Pharmacology, University of Pennsyl- 
vania, Philadelphia, PA), respectively. “’I-PIN was prepared by a 
modification of the method of Barovsky and Brooker (7). 
Cell Culture-Human astrocytoma cells (1321N1) and rat glioma 
cells (C62B, passage 30-40)  were  grown as previously described (1). 
Cells taken from confluent flasks were  seeded in 35-mm culture dishes 
(Falcon) a t  a density of 80,000 cells/dish and used on the 4th day 
following subculture. 
Intact Cell Receptor  Binding Assays-Intact cells were incubated 
at 37 “C with various concentrations of 0-adrenergic ligands in growth 
’ In many of the experiments reported here, the competing ligands 
do not attain equilibrium with a subpopulation of cellular 0-adrener- 
gic receptors during the  short time assays employed to study  their 
interaction with the receptors. The IC, values obtained therefore are 
not reflective of the true affinity of the receptor for these ligands but 
rather represent an  “apparent affinity” for these ligands under the 
particular assay conditions employed. While the model used for 
computerized curve-fitting is not entirely correct in these instances, 
the shape of a “pre-equilibrium” competition curve is sufficiently 
similar to  that for the equilibrium situation to allow  use of this model 
for estimating the fractions of receptors in the high and low apparent 
affinity forms. 
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medium containing  1 mM sodium ascorbate. Control cells were incu- 
bated under the same conditions with ascorbate only. The cell sheets 
were then rinsed 2 or 3 times with serum-free Eagle's  medium 
containing 20 mM Hepes (pH 7.4) a t  37 "C. Binding to intact cell p- 
adrenergic receptors in the presence of varying concentrations of 
competing ligands was then measured in  15-s assays with 100 PM lZ5I- 
PIN as previously described (1). In some experiments, desensitized 
cells were incubated for different times with varying concentrations 
of competing ligand to allow equilibration of the ligand with the 
various forms of the receptor prior to performing short  time binding 
assays. Specific binding in the absence of competing drugs in 1321N1 
cells was approximately 1500 cpm bound/assay and in C62B cells was 
approximately 500  cpm bound/assay. Nonspecific binding, measured 
in each experiment as  that occurring in the presence of 1 p~ pro- 
pranolol, was about 15% of total binding for 1321N1 cells and 30% 
for C62B cells. In all cases where tested, the results obtained with 
control cells (incubated with ascorbate) were essentially identical 
with those obtained with naive cells (1). 
Cyclic AMP Accumulation in Intact Cells-Intact cells were incu- 
bated at 37  "C in the absence or presence of isoproterenol in growth 
medium containing 1 mM sodium ascorbate. The cell sheets were 
then rinsed three times (2 ml each) with Eagle's-Hepes at 37 "C. 
Cellular accumulations of cyclic AMP in response to isoproterenol 
were then measured using a modification of the method of Shimizu 
et al. (9) similar to  that previously described (10). One ml of Eagle's- 
Hepes containing 1 mM sodium ascorbate, [3H]adenine (approxi- 
mately 5 pCi/ml), and varying concentrations of isoproterenol was 
added to each dish. Following a 1-min incubation at 37  "C this 
medium was aspirated and 1 ml of 5% trichloroacetic acid was added. 
The amounts of [3H]ATP  and [3H]cAMP  present in the trichloroace- 
tic acid-soluble fractions were then determined using a modification 
(11) of the method of Salomon et al. (12). 
Data Analysis-As documented in  a previous report ( l ) ,  the IC, 
obtained for a competing ligand in these short time assays under 
conditions approximating the initial  rate of radioligand binding pro- 
vides an estimate of the  true affinity of the receptor for competing 
ligands that  attain equilibrium with the receptor very rapidly. For 
competing ligands that  attain equilibrium slowly relative to  the time 
of the assay, the observed IC, will  be larger than  the  true KO, and 
changes in the observed IC, with time  can provide a measure of the 
approach to equilibrium of the competitor with the receptor (13, 14). 
Competition curves were analyzed by computerized nonlinear least 
squares curve fitting of the raw data using the Gauss-Newton or 
Marquardt methods (15). The model used was that for law of mass 
action interaction of the competing ligand with either  a single site (n 
= 1) or two independent sites ( n  = 2)  as follows: 
where s is the concentration of competing ligand, B, is the concentra- 
tion of '=I-PIN bound at a given value of S,  B; is the concentration 
of lZ5I-PIN bound to each site  in the absence of competitor, I ,  is the 
concentration of competing ligand which reduces the amount of lZ6I- 
PIN bound to site i by 50% (the IC,), and N is the concentration of 
nonspecific binding sites. It should be noted that  this model  will  be 
correct only if the competing ligand is at equilibrium with all specific 
binding sites under the conditions of the assay.' 
Comparison of the single site and two-site models was done as 
previously desribed (16). Values reported for fractions of high and 
low apparent affinity binding sites  are reported as  arithmetic means; 
IC, and KO values are reported as geometric means (17). For all 
competition curves, data  are expressed as  the percentage of  '"I-PIN 
specifically bound in the absence of competitor. The averages of the 
experimental data points are shown together with the curve for the 
computer-derived fit of the data. The amount of binding in the 
presence of 1 p~ propranolol (nonspecific) is also indicated. Standard 
errors of all points on the curves were generally less than  5% of the 
amount specifically bound in the absence of competitor. 
RESULTS 
Agonist-induced  Conversion of  Intact 1321Nl Cell 0-Adre- 
nergic Receptors to a  Form  with Low Apparent  Affinity2 For 
Isoproterenol  in Short Time Assays-Human astrocytoma 
cells (1321N1) were incubated for 20 min at  37 "C in the 
absence or presence of various concentrations of isoproter- 
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FIG. 1. Isoproterenol competition curves with 1321NI cells 
preincubated without or with isoproterenol. 1321N1 cells were 
incubated at 37 "C for 20 min without (0) or with 10 nM (A) or 1 PM 
(0) isoproterenol and  then rinsed twice. Binding of 1Z61-PIN to intact 
cells was then measured in 15-s assays in the presence of the indicated 
concentrations of isoproterenol as described under "Experimental 
Procedures." The  data points  are the average of four determinations 
from two or three separate experiments. 
enol. The cell sheets were then rinsed two times over a period 
of 1 min to remove the preincubation medium, in particular 
to reduce the isoproterenol concentration by several orders of 
magnitude. Isoproterenol competition for lZ5I-PIN binding 
was then measured in  15-s binding assays (Fig. 1). In all cases 
the  data were significantly better fit (p < 0.05)  by a two-site 
law of mass action binding model than by a single-site model. 
In control cells the majority of 1251-PIN binding (83 & 5%, n 
= 3) was inhibited with an IC50 of 53 k 17 nM, whereas the 
remainder (17%) was inhibited only at  much higher concen- 
trations of isoproterenol (IC50 = 520 f 930 pM). With increas- 
ing concentrations of isoproterenol during the preincubation 
period, there was a progressive decrease in the fraction of 
receptors exhibiting high affinity for isoproterenol and a 
corresponding increase in  the fraction of receptors exhibiting 
lower apparent affinity for isoproterenol. The amount of 1251- 
PIN bound in the absence of competitor remained constant 
or decreased ~l ight ly .~ Changes in the IC,, values for isopro- 
terenol at  the two types of lZ5I-PIN binding sites were very 
small. Thus, following preincubation with 10 nM isoproter- 
enol, 61 -+ 5% ( n  = 2) of '*,I-PIN binding was inhibited with 
an IC50  of 170 +- 82 nM and  the remaining 39% was inhibited 
with an IC50 of 710 f 600 PM. When the preincubation was 
with 1 p M  isoproterenol, 37 f 6% ( n  = 3) of 1251-PIN binding 
was inhibited with an ICs0  of 120 f 90 nM and  the remaining 
In the experiments reported here, the amount of 1'51-PIN bound 
in the absence of competitor to cells preincubated with 1 p~ isopro- 
terenol was 95 f 10% ( n  = 6) of the amount bound to control cells 
under the same conditions. In early experiments (not shown) cells 
were rinsed only once following preincubation with isoproterenol and 
then 1-min binding assays were performed using 25 PM Iz6I-PIN. In 
these assays, desensitized cells exhibited 10-25% more binding in the 
absence of competitor than did control cells. This increase in the rate 
of radioligand binding to desensitized cells occurred in  spite of a 10- 
15% decrease in the total number of assayable receptors as measured 
in membrane preparations from such cells or in intact cells assayed 
for 1 min with extremely high concentrations of radioligand so that 
all receptors would be labeled even in  a  1-min assay. Whether the 
failure to observe this phenomenon in the assays reported here results 
from the more effective removal of isoproterenol with additional 
rinses or from the shorter assay time and higher concentration of 
radioligand employed has  not been determined. This result may  be 
related to a similar change in the apparent  rate of antagonist binding 
to S49 lymphoma cells reported by Reynolds et al. (18). 
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63% was inhibited  with an IC,  of 840 f 41 pM. 
Slow Equilibration of Isoproterenol with Those Receptors 
Exhibiting Low Apparent Affinity in  Short Time Assays-The 
results above show that incubation of cells in the presence of 
a /?-adrenergic agonist  converts  a  portion of the @-adrenergic 
receptors from a form exhibiting high affinity for isoproter- 
enol to a form of lower apparent affinity. However, the ICs0 
value for this form of the receptor observed following prein- 
cubation with agonist was considerably higher than  the KO 
value of 11 PM obtained  in equilibrium competition binding 
assays  with isoproterenol (1). If isoproterenol came to equilib- 
rium slowly with this  altered form of the receptor present  in 
cells preincubated with isoproterenol, then competition curves 
obtained at  short times of binding might be expected to be 
shifted to  the right relative to  the curve obtained at  equilib- 
rium (1). The experiment shown in Fig. 2 demonstrates that 
in  fact this was the case. Following 20 min preincubation with 
isoproterenol (1 p ~ )  to induce formation of the altered form 
of the receptor and washing to remove isoproterenol, cells 
were further incubated with the indicated  concentrations of 
isoproterenol in the absence of 1251-PIN for various times to 
allow isoproterenol to approach equilibrium with the altered 
form of the receptor. Binding of 1251-PIN to these cells was 
then determined  in 15-s assays in  the continued presence of 
the indicated  concentrations of isoproterenol. The curve ob- 
tained without  pre-equilibration with isoproterenol (from Fig. 
1) is included for comparison. With increasing time of equi- 
libration with isoproterenol, there was a progressive leftward 
shift of the “low affinity  portion” of the competition curves. 
This is the result expected if isoproterenol comes to equilib- 
rium slowly with the  altered form of the receptor. Following 
a l-min equilibration with isoproterenol, 38 f 7% (n = 3) of 
1251-PIN binding was inhibited with an IC,, of 66 f 52 nM 
and  the remaining 62% was inhibited  with an ICs0  of  69 f 34 
PM. With 2- or 5-min equilibration (data not shown) there 
was a further leftward shift  in  this portion of the competition 
curves. There was no change in the high affinity  portion of 
the competition curves, indicating that isoproterenol equili- 
brates very rapidly with the high affinity  receptors  remaining 
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FIG. 2. Apparent slow equilibration of isoproterenol with 
low affinity receptors. 1321N1 cells were incubated at 37 “C for 
20 min in the presence of 1 PM isoproterenol and  then rinsed three 
times. One ml  of Eagle’s-Hepes containing 1 mM sodium ascorbate 
and  the indicated concentrations of isoproterenol was then added to 
each dish and  the cells were further incubated at 37 “C for either 1 
min (0) or 60 min (0). This medium was then aspirated and ‘?-PIN 
binding was measured in 15-s assays as described under  “Experimen- 
tal Procedures.” The curve from Fig. 1 for cells with no “pre-equili- 
bration” with isoproterenol between the “preincubation” and assay 
steps is included for comparison (A). The  data  are  the averages of 
three  experiments with duplicate determinations at  each point. 
in these cells just  as in  control cells. 
Following 60 min equilibration, 34 f 16% (n = 3) of lZ5I- 
PIN binding appeared to be inhibited with an IC5,  of 180 f 
220 nM and  the remaining 66% with an IC,  of  7.9 f 4.9 pM. 
This latter value is essentially the same as that obtained 
previously in equilibrium competition binding assays with 
naive cells (11 p ~ ,  Ref. 1) and is about 100-fold higher than 
the high affinity value obtained with control cells (Fig. 1). 
However, it should be noted that this curve may reflect 
processes in  addition to competition by isoproterenol for ‘‘,I- 
PIN binding sites. At the very low concentrations of isopro- 
terenol, some reversal of the agonist-induced change in  bind- 
ing properties of the receptors is most likely occurring during 
the 60-min incubation, whereas at  the higher concentrations 
of isoproterenol, agonist-induced loss of receptors will be 
occurring (19). Thus, both the total number of receptors 
present and  their distribution among the various forms being 
studied will probably be different for each point on this 
portion of the competition curve. We  believe it is most likely 
that  the  apparent high affinity competition observed under 
these  conditions actually represents  a dose-response curve for 
agonist-induced receptor loss. 
Antagonist Binding Properties of Receptors on Agonist-pre- 
treated 1321N1 Cells-The results  presented above show that 
preincubation of cells with isoproterenol leads to a  dramatic 
change in the agonist binding properties of a portion of the 
cellular @-adrenergic receptors. To determine whether the 
antagonist binding properties of intact cell receptors were also 
changed following exposure to isoproterenol, short time com- 
petition binding assays were performed with the antagonists 
metopro;ol and sotalol on cells preincubated without or with 
1 p~ isoproterenol. Preincubation with isoproterenol did not 
cause a significant change in the shape or position of the 
competition curve obtained with metoprolol (Fig.  3A). In both 
cases the curves indicated interaction of metoprolol with a 
single class of sites, with an IC50 of 390 f 98 nM (n = 2) in 
control cells and 500 f 210 nM (n = 2) in cells preincubated 
with isoproterenol. 
The curves obtained with the antagonist sotalol (Fig. 3B) 
were better fit by a two-site binding model than by a single- 
site model and in fact were quite similar to those obtained 
with isoproterenol (Fig. 1). With  control cells, 85 f 5%  (n = 
3) of lZ5I-PIN binding was inhibited with an IC,,  of  210 f 72 
nM and  the remaining 15% was inhibited with an ICs0  of  320 
f 670 pM. In cells preincubated with isoproterenol, 29 f 8% 
(n = 3) of lZ5I-PIN binding was inhibited with an IC,,  of  200 
& 250 nM and  the remaining 71% was inhibited with an ICso 
O f  180 f 100 pM. 
Competition by sotalol for lZ5I-PIN binding sites also was 
measured in 15-s assays with naive cells and with cells prein- 
cubated for 60 min with varying concentrations of sotalol 
prior to assay (Fig. 4). The curve obtained with naive cells 
was similar to  that shown for control cells in Fig.  3, with 79 
f 5% (n = 2) of ‘251-PIN binding inhibited with an IC5, of 
100 f 30 nM and  the remaining 21% inhibited with an IC, of 
240 f 270 yM. The  data obtained with cells pre-equilibrated 
with  sotalol prior to assay indicated that nearly all (93 f 3%, 
n = 4) of the lZ5I-PIN binding sites under these conditions 
exhibited high affinity for sotalol (IC5, = 77 f 10 nM) and 
that very few receptors remained in the low apparent affinity 
form (7%, IC50 = 960 f 2000 pM).  These  results suggest that 
the binding sites exhibiting low apparent affinity for sotalol 
in 15-s assays in fact  result from slow equilibration of sotalol 
with a population of receptors which exhibit high affinity 
once equilibrium is  attained. 
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bated without and with  isoproterenol. 1321N1 cells were prein- 
FIG. 3. Antagonist competition curves from cells preincu- 
cubated without (0) or with (0) 1 p~ isoproterenol at 37 "C for 20 
min and  then rinsed twice prior to performing 15-s binding assays in 
the presence of the indicated concentrations of metoprolol (A)  or 




-6 -5 -4 -3 - 2  P 
[SOTALOL] ( log M 1 
FIG. 4. Sotalol competition curves  with naive 1321N1 cells. 
1321N1 cells were rinsed once with Eagle's-Hepes and  then either 
assayed immediately in 15-s assays in the presence of the indicated 
concentrations of sotalol (0) or incubated for 60 min  in the presence 
of the indicated concentrations of sotalol prior to 15-s assays in the 
presence of the indicated concentrations of sotalol (0). The data 
points  are  the averages of 2-4 separate experiments. 
ceptor Binding  Properties and Its Reversal-To further study 
the preincubation  time and concentration dependence of this 
change in receptor binding properties and its reversal, the 
ability of 10 PM isoproterenol to inhibit specific binding of 
lZ5I-PIN was measured in 15-s assays following preincubation 
under various conditions. From the  data in Fig. 1 it can be 
seen that  the per cent of specific binding in the presence of 
10 PM isoproterenol provides a good estimate of the fraction 
of receptors exhibiting  altered binding properties. The time 
course for formation of this form of the receptor during 
incubation with 1 PM isoproterenol is shown in Fig. 5A. There 
was a lag of 30-45 s before any change in binding was detected; 
the reaction then occurred rapidly, with a t 1 / 2  of 1-2 min, and 
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FIG. 5.  Time and isoproterenol concentration dependence 
of formation of the low affinity form of intact cell receptors. 
In each of the experiments presented above, 1321N1 cells were 
incubated at 37 "C without (0) or with (0) isoproterenol as described 
below and  then rinsed three times with Eagle's-Hepes at 37 "C. "'I- 
PIN binding was then measured in 15-s assays in the absence of 
competitor (B(O)) ,  in the presence of 10 pM isoproterenol (B(n ) ,  or 
in the presence of 1 p~ propranolol (B(P) ,  nonspecific binding). The 
specific binding in the presence of 10 p~ isoproterenol (B(n-B(P))  is
expressed as a percentage of specific binding in the absence of 
competitor (B(0)-B(P)) .  A, cells were incubated with 1 pM isoproter- 
enol for the times indicated prior to performing binding assays. B, 
cells were incubated with 1 /IM isoproterenol for 20 min, washed 3 
times with growth medium, and  then further incubated at 37 "C for 
the indicated times prior to performing binding assays. C, cells were 
incubated for 20 min in the presence of the indicated concentrations 
of isoproterenol prior to performing binding assays. The  data points 
are the averages of two experiments. 
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appeared  to  have  reached a steady  state level by 5 min,  with 
60-70% of the receptors exhibiting low apparent affinity. 
With longer times of incubation  (up  to 2  h, data  not  shown), 
the  total  number of lZ5I-PIN  binding  sites began to decrease, 
but  the  fraction of these  sites  exhibiting high and low apparent 
affinity for isoproterenol remained constant. The reversal 
reaction was monitored following 20 min  incubation  with 1 
PM isoproterenol  and  then  three  washes  to remove isoproter- 
enol. The reversal reaction  occurred  with a tl/z of  6-8 min  and 
was complete by 60 min (Fig. 5B).  Thus,  the forward  reaction 
is slow enough that conversion of receptors to the altered 
form during the 15-s assays should not contribute to the 
results  obtained  in  the  various  experiments  using 15-s assays. 
Likewise, the reversal reaction  is slow enough that  no signif- 
icant reversal should be occurring  during  the 1min of washing 
employed between the preincubation and assay steps. The 
extent of conversion of receptors  to  the  form  exhibiting low 
apparent  affinity for isoproterenol also was measured follow- 
ing 20  min preincubation  with various concentrations of iso- 
proterenol (Fig. 5C); half-maximal conversion of receptors to 
this form was observed with  15 nM isoproterenol. 
Ligand  Specificity  for  Formation  and  Detection  of  the  Altered 
Form of Intact Cell Receptors-Assays similar  to  that above 
were used to  investigate  the  ability of a variety of ligands to 
induce conversion of receptors to the form exhibiting low 
apparent affinity for isoproterenol (Table I). All agonists 
tested  induced  similar  changes  in  the  binding  properties of 
the  receptor for the  agonists  isoproterenol  and  epinephrine 
and  the  antagonist sotalol. The  partial  agonists  soterenol  and 
terbutaline  induced  smaller conversions of receptors to  the 
altered form than did the full agonists. Furthermore, their 
efficacies (relative  to  isoproterenol) for inducing  this  change 
in  the  binding  properties of the  receptor were similar  to  their 
relative  efficacies for  stimulation of cyclic AMP  accumulation 
in intact  1321N1 cells (about 35%  for soterenol  and 60% for 
TABLE I 
Ability of 8-adrenergic  ligands  to  induce  and  detect  a low apparent 
affinity form of the  8-adrenergic receptor 
1321N1 cells were incubated for 20 min at 37 "C in the presence of 
the indicated concentrations of @-adrenergic receptor ligands. The 
cells were then washed 2-3 times with Eagle's-Hepes at  37 "C. '=I- 
PIN binding was then measured in 15-s assays at 37 "C in the presence 
of the indicated concentrations of various competing ligands. Binding 
in the presence of the competing ligands is expressed as a percentage 
of the  total specific binding in the absence of competitor. The results 
shown are the averages of 2-3 separate experiments; standard errors 
were generally less than 5% of the total specific binding in the absence 
of competitor. 
% binding  in presence of 
terbutaline).  Antagonists  had  no effect on  the  distribution of 
receptors between the two  forms. None of the ligands tested 
altered  the  apparent  affinity of the receptor  for metoprolol. 
Isoproterenol-stimulated Cyclic A M P  Accumulation in Con- 
trol and  Desensitized 1321N1 Cells-The possible relationship 
between the conversion of receptors to the low apparent 
affinity form  and  the loss of responsiveness to isoproterenol 
of the cyclic AMP generating system of 1321N1 cells was 
investigated.  Cells were preincubated  with varying concentra- 
tions of isoproterenol for 20 min, washed, and then cyclic 
AMP accumulation was measured in response to varying 
concentrations of isoproterenol in  1-min  assays (Fig. 6 ) .  With 
increasing  concentrations of isoproterenol during  the  prein- 
cubation, a  progressive  decrease in  the maximal level of cyclic 
AMP accumulation was observed. A small increase in the 
value of K,,, from 15 nM in control cells to 50 nM in cells 
preincubated  with  isoproterenol also was observed. These Kact 
values are  similar  to  the KD values  for binding of isoproterenol 
to  the high affinity form of the receptor on intact cells. It 
should be noted  that maximal cyclic AMP accumulation oc- 
curred by 1 PM isoproterenol and  that  no  further increase in 
cyclic AMP  accumulation was observed in  either  control  or 
desensitized cells at  the higher concentrations of isoproterenol 
where binding  to  the low apparent  affinity form of the receptor 
occurs. Thus,  the receptors exhibiting  the low apparent  affin- 
ity for  isoproterenol  in short  time  assays  appear  to be uncou- 
pled from the cyclic AMP  generating system. Furthermore, 
the  fractional  stimulation of CAMP  accumulation  remaining 
following various preincubation conditions correlates well 
with the  fraction of receptors remaining in the high agonist- 
affinity  form (Fig. 1). 
Intact Cell Binding  Studies  with  Control  and  Desensitized 
C62B Cells-To determine  whether  similar  changes in  recep- 
tor  binding  properties occur upon exposure of C62B cells to 
agonists, analogous experiments were performed with these 
cells. Fig. 7 shows the competition curves obtained in 15-s 
assays with isoproterenol, metoprolol, and sotalol in C62B 
cells preincubated  without or with  isoproterenol (1 KM for 20 
min).  In all  cases, preincubation with  isoproterenol led to a 
20-30% decrease in the amount of '251-PIN bound in the 
absence of competing ligand. The  competition curve obtained 
with isoproterenol (Fig. 7 A )  in  control cells, like that previ- 
ously obtained  in naive cells (l), was better  fit by a two-site 
binding model, with 69 k 5% (n  = 3) of lZ5I-PIN binding 
inhibited with an IC50 of 83 & 28 nM and  the  remaining 31% 
I I r I I 
c 1 
Preincubation  Isopr ter-  Epin ph- S alol rine Metoprolol enol 
(10 I" (10 uM)  uM) (0'3 PM)  
J I 
-1 
. . .  . , ~ I  r ,  
Control 12 23 16 54 
1 p~ Isoproterenol 71 68 58 50 
1 p~ Epinephrine 78  79 74 48 
1 p~ Sotalol" 4 14 2 53 
1 p~ Metoprolol 14 21 16 54 
1 p~ SoterenoP 26 
10 PM Terbutaline* 40 
a The decrease in binding to  the low apparent affinity form of the 
receptor observed following preincubation with sotalol may reflect 
incomplete dissociation and removal of sotalol during the 1-min wash 
prior to  the binding assay, due to  its relatively high affinity and slow 
membrane permeability. 
*No greater formation of the altered form of the receptors was 
observed when the preincubation was done with 10-fold higher con- 
centrations of these partial agonists, indicating that  the concentra- 
tions used were maximally effective. 
FIG. 6. Accumulation of cyclic AMP in response to isopro- 
terenol by 1321N1 cells. Cells  were incubated at 37 "C for 20 min 
without (a) or with 10 nM (A) or 1 pM (0) isoproterenol and  then 
rinsed three times with Eagle's-Hepes. The amount of [3H]cAMP 
formed in response to  the indicated concentrations of isoproterenol 
was then measured as described under "Experimental Procedures." 
The  data points shown are  the averages of duplicate determinations 
from a single experiment. Similar results were obtained in two addi- 
tional experiments. 
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FIG. 7. Competition curves obtained with C62B  cells incu- 
bated without or with isoproterenol. C62B cells were incubated 
for 20 min at 37 "C without (0) or with (0) 1 &M isoproterenol and 
then rinsed three times. Binding of lZ5I-PIN was then measured in 
15-s assays in the presence of the indicated concentrations of isopro- 
terenol, metoprolol, or sotalol. The data are the averages of 2-4 
separate experiments for each curve. 
inhibited with an IC50 of  320 f 260 p ~ .  In cells preincubated 
with isoproterenol (Fig. 7A), 34 f 5% (n = 3) of lZ5I-PIN 
binding was inhibited with an ICso of 54 2 45 nM and  the 
remaining 66% was inhibited with an IC50 of 470 f 220 pM. 
The curves obtained  with metoprolol (Fig. 7B) in  both  control 
cells and cells preincubated with isoproterenol indicated in- 
teraction  with  a single class of sites; in control cells the ICs0 
was 200 f 46 p~ (n = 2), and in cells preincubated with 
isoproterenol the IC50  was  170 f 58 pM (n = 2). The compe- 
tition curves obtained with sotalol (Fig. 7C), like those for 
isoproterenol, indicated interaction with two sites. In control 
cells, 74 2 5% (n = 3) of lZ5I-PIN binding was inhibited with 
an IC50 of 870 2 260 nM and  the remaining 26% was inhibited 
with an ICso of 550 f 540 p ~ .  In cells preincubated with 
isoproterenol, 44 f 6% (n = 3) of lZ5I-PIN binding was 
inhibited with an IC5o of 350 f 220 nM and  the remaining 
56% was inhibited with an IC50 of 400 2 220 p ~ .  Thus,  the 
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FIG. 8. Accumulation of cyclic AMP in response to isopro- 
terenol by C62B  cells. C62B cells were incubated without (0) or 
with (0) 1 PM isoproterenol for 20 min and  then rinsed three  times 
with Eagle's-Hepes. The amount of [3H]cAMP formed in response to 
the indicated concentrations of isoproterenol was then measured as 
described under "Experimental Procedures." The  data points shown 
are from a single experiment with duplicate determinations at each 
point. Similar results were obtained in two additional experiments. 
results obtained with all three ligands in C62B cells are 
analogous to those  obtained with the 1321N1 cells. 
Isoproterenol-stimulated Cyclic AMP Accumulation in Con- 
trol and Desensitized C62B  Cells-The effect of preincubation 
with isoproterenol on subsequent isoproterenol-stimulated 
cyclic AMP accumulation in 1-min  assays also was measured 
in C62B cells (Fig. 8). Following 20 min preincubation with 1 
p~ isoproterenol, there was an increase in Kact from 2-3 to 8- 
10 nM and a 30-40% increase in the maximal response ob- 
served. The  apparent increase in the basal level of cyclic AMP 
accumulation in cells preincubated with isoproterenol most 
likely results from incomplete removal of isoproterenol prior 
to  the assay; however, residual isoproterenol from the prein- 
cubation step cannot explain the increase in maximal re- 
sponse observed in the presence of higher concentrations of 
isoproterenol. With longer times of incubation (data not 
shown) there was further loss of lZ5I-PIN binding sites and a 
progressive decrease in maximal response; however, a  portion 
of this decrease may  be due to heterologous types of desensi- 
tization (20) rather  than simply due to  further decreases in 
the number of high affinity receptors. 
DISCUSSION 
In  short time assays with control 1321N1 cells, isoproter- 
enol distinguishes two populations of receptors, the majority 
(about 85%) exhibiting high affinity for isoproterenol (50-100 
nM) and  the remainder exhibiting very low apparent affinity' 
(500-1000 PM). Exposure of these cells to isoproterenol for a 
period prior to such short time  assays does not change the 
total amount of lZ5I-PIN binding in the absence of competitor, 
but  rather causes a decrease in  the fraction of high affinity 
receptors and corresponding increase in  the fraction of recep- 
tors exhibiting the lower apparent affinity. This change in 
agonist binding properties is not brought about by exposure 
of cells to antagonists. Exposure of cells to  partial agonists 
results  in conversion of a smaller fraction of the receptors to 
the altered form. The reaction occurs rapidly and is fully 
reversible. The for isoproterenol for this reaction is sim- 
ilar to  that for stimulation of cyclic AMP accumulation in 
these cells (Fig. 6) and to that for induction of receptor- 
specific desensitization (19). 
The ability to detect  a form of the receptor exhibiting very 
low apparent affinity in short time assays, both in control 
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cells and in cells preincubated  with agonists, does not depend 
simply upon whether the competing ligand used is an agonist 
or  an antagonist, since these  phenomena occur for the  antag- 
onist sotalol as well as for the agonists isoproterenol and 
epinehrine (Figs. 1-4 and  Table I). In  contrast,  the antago- 
nists metoprolol (Fig. 3)  and propranolol (data not shown) 
exhibited single site, high affinity competition in both  control 
cells and in cells preincubated with agonist. These  agonists 
and sotalol  are more hydrophilic ligands than metoprolol and 
propranolol (21, 22), and we propose that  it is this property 
of these ligands that is responsible for the low apparent 
affinity observed in short time assays. The very low apparent 
affinity for hydrophilic ligands of the altered form of the 
receptor observed in 15-s assays with cells pre-exposed to 
agonist most likely results from slow equilibration of isopro- 
terenol  with this population of receptors (Fig. 2). We discuss 
below a model that can explain both the low apparent affinity 
for hydrophilic ligands in  short time  assays and  the  apparent 
slow equilibration of these ligands with the altered form of 
the receptor. 
A small fraction of the receptors exhibited low apparent 
affinity for agonists even in  control cells (Fig. 1). This could 
result from rapid  formation of the altered form of the receptor 
even during the short assays used here, or alternatively it 
could indicate that even in  the native state a  portion of the 
receptors  exist  in  a form with  properties  similar to  that formed 
upon incubation with agonists. The results presented for 
sotalol competition in Fig. 3B argue strongly in favor of the 
latter explanation.  Sotalol does not induce formation of the 
altered form of the receptor, yet a similar fraction of the 
receptors in control cells exhibit low apparent affinity for 
sotalol  in short time  assays as for isoproterenol. In addition, 
if rapid  formation  during the assay were to account for these 
low apparent affinity receptors, the process for their forma- 
tion would have to occur much more rapidly than indicated 
by the time course shown in  Fig. 5 .  These  receptors  in  control 
cells exhibit affinities for both isoproterenol and sotalol in 
short time assays that are similar to those of the altered 
receptors formed upon preincubation with agonists. In addi- 
tion, sotalol apparently exhibits the same phenomenon of 
slow equilibration  with this population of receptors in naive 
cells as isoproterenol does with the altered receptors formed 
during  incubation with agonists. Taken together,  these  results 
suggest that in control cells a portion of the p-adrenergic 
receptors  exist  in  a form of  low apparent agonist  affinity that 
may be the same as that formed upon incubation in the 
presence of agonists. 
Results  obtained  in our studies with the C62B  cell line (Fig. 
7) were completely analogous to those with 1321N1 cells, and 
the results  obtained by Pittman  and Molinoff (8) with L6 rat 
muscle cells suggested that a  similar reaction might occur in 
this cell line. However, they did not show full competition 
curves and so it is not possible to  tell whether  a  portion of 
the receptors in control L6 cells also exhibit low apparent 
affinity for agonists, nor is it possible from their results to 
quantitatively  determine the affinity of the receptors in these 
cells in  the native state. Preliminary  reports (18, 23)4 indicate 
that a  similar reaction also occurs in S49 mouse lymphoma 
cells. Taken together, these results suggest that a reaction 
‘Note Added in Proof-After submission of this manuscript a 
publication  appeared  on the same subject (Insel et al. (1983) J.  Bioi. 
Chem. 258, 13597-13605). The results of Insel et al. are complemen- 
tary  to our previous  results (1) and  to  the results  presented in this 
article. They extend the basic observation of an agonist-induced, 
time-dependent formation of an altered form of the P-adrenergic 
receptor to  the S49 mouse lymphoma cell line. 
similar to  that described here may be a general feature of p- 
adrenergic receptor modulation by agonists. 
To determine the possible relationship of the changes in 
receptor binding properties reported here to agonist-induced 
desensitization, we studied agonist-induced cyclic AMP ac- 
cumulation under short time assay conditions similar to those 
used to study binding to  intact cell receptors. In 1321N1 cells, 
preincubation with isoproterenol for 20 min led to a concen- 
tration-dependent decrease in the maximal cyclic AMP re- 
sponse, along with a 2-3-fold increase in  the value of KaCt. 
The decrease in maximal response correlated reasonably well 
with the fraction of receptors converted from the high affinity 
form to  the altered form. These  results suggest that in  these 
cells the full complement of high affinity receptors is required 
to maintain maximal hormone responsiveness. 
The results  obtained with the C62B cells were somewhat 
different. Preincubation for 20 min with a saturating concen- 
tration (1 FM) of isoproterenol did not lead to  any decrease 
in the maximal response, but  rather  to a small increase in 
maximal response together with a %fold increase in Kad. This 
is in spite of a 30% decrease in the  total number of assayable 
receptors and a shift of approximately half of the remaining 
receptors from the high affinity form to the altered form. 
These cells can thus maintain the same level of maximum 
responsiveness to isoproterenol in spite of a %fold decrease 
in the number of high affinity receptors. This result is con- 
sistent with previous studies (24, 25)  which suggest that  the 
C62B  cell line may have a high efficiency of coupling of p- 
adrenergic receptors to adenylate cyclase and/or some degree 
of “spareness” of receptors. 
Several characteristics of the altered form of the receptor 
produced upon incubation with agonists lead us to suggest 
that  it is most likely present inside the cell within an endo- 
cytotic vesicle. Hydrophilic ligands, such as isoproterenol, 
epinephrine, and sotalol, would  be expected to diffuse across 
the plasma membrane of intact cells only slowly. Thus, in 
short time assays, the concentration of these hydrophilic 
ligands inside the cell  would  be much lower than  the concen- 
tration outside the cell and little inhibition of radioligand 
binding to internalized receptors would  be seen at  concentra- 
tions of competing ligand that would effectively block binding 
to cell surface receptors. However, at  very  high concentrations 
of hydrophilic ligand, sufficient permeation of competing li- 
gand into  the cell  would occur to  inhibit radioligand binding 
to internalized receptors as well, even in very short assays. 
With increasing time of exposure to varying concentrations 
of competing hydrophilic ligand, further permeation of ligand 
into  the intracellular  compartment  containing the  internal- 
ized receptor would occur, and  the concentration of competi- 
tor required outside the cell to achieve an effective inhibitory 
concentration inside the cell  would decrease, thus leading to 
a leftward shift in the observed competition curve. The idea 
of internalized receptors could thus explain both the low 
apparent affinity observed in short time assays as well as  the 
apparent slow equilibration observed with hydrophilic ligands. 
The slow equilibration of these ligands would then not be due 
to a slow rate of interaction of the ligand with the receptor 
but rather  an  artifact due to slow permeation of the ligand 
into  the cellular compartment  containing  these receptors. The 
more lipophilic ligands metoprolol and propranolol might be 
expected to freely diffuse through the plasma membrane, and 
thus even at  short assay  times  these ligands would appear to 
bind with equal affinity to both cell surface and internalized 
receptors; thus,  a single class of binding sites would be ob- 
served, both in control cells and in desensitized cells. 
Previously reported studies from this laboratory also are 
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consistent with the idea of agonist-induced internalization of 
@-adrenergic receptors (26). Sucrose density gradient centrif- 
ugation studies of @adrenergic receptors  in membrane prep- 
arations from both control 1321N1 cells and cells preincu- 
bated  with  agonists were performed. In control cells, the bulk 
of the receptors  migrated  in  a heavy density  fraction  together 
with markers for the plasma membrane, with a small fraction 
of the receptors migrating  in  a light vesicle fraction. In desen- 
sitized cells, there was an  apparent  shift of about half of the 
receptors from the heavy fractions to  the light fractions.  These 
light peak receptors were interpreted  as evidence for agonist- 
induced internalization of receptors within endocytotic vesi- 
cles. Similar  results also were obtained with C62B cells (27). 
We propose that the receptors exhibiting low apparent 
affinity for agonists in  control cells in the present  study are 
those migrating in the light peak in membranes prepared from 
these cells, and  that  the increase in this population of recep- 
tors upon desensitization corresponds with the increase in 
light peak receptors in  membranes from desensitized cells. In 
both  control and desensitized cells, the proportions of total 
cellular receptors in  the high and low apparent affinity forms 
correspond to  the proportions of receptors in the heavy and 
light peak fractions, respectively, in membrane preparations 
(26). The time courses for agonist-induced formation of light 
peak receptors (28) and for formation of the altered form of 
the receptor as measured in the present  study (Fig. 5 )  are very 
similar, including in both cases the presence of a 30-45 s lag 
before any altered receptors can be detected. The agonist 
concentration dependence of these two phenomena and  the 
time courses for their reversal are also similar (Fig. 5 and 
Refs. 26 and 28). In addition, pretreatment of cells with 
concanavalin A  prior to incubation  in the presence of agonist 
prevents both the  alteration  in receptor binding properties 
described here5 and  the formation of light peak receptors (28), 
but does not block the agonist-induced uncoupling of @- 
adrenergic receptors from adenylate cyclase. If in fact the 
altered receptors are intracellular as we postulate, then those 
present in control cells might be an indication of continuous 
recycling of receptors between intracellular and cell surface 
compartments even in the absence of agonists or might rep- 
resent newly synthesized receptors  not yet transported  to  the 
cell surface. 
Recently reported studies of @-adrenergic receptors on in- 
tact C62B cells using the radioligand 3H-CGP-12177 also are 
consistent with the idea of receptor internalization (29-31). 
This radioligand is relatively hydrophilic and appears to label 
only cell surface receptors (29,30).  In control cells, isoproter- 
enol exhibits high affinity competition for 3H-CGP-12177 
binding sites even in equilibrium binding assays (30). This 
result would  be expected if the altered  receptors are  in fact 
internalized and  thus unavailable for binding of this hydro- 
philic radioligand. Preincubation of cells with isoproterenol 
leads to an approximately 50% decrease in the number of 
receptors available for binding of this ligand (29),  consistent 
with internalization of half of the receptors. Whether the 
remaining cell surface binding sites for this ligand retain high 
affinity for agonists was not  presented,  although the results 
obtained  in the equilibrium competition binding assays (30) 
would suggest that  this would  be the case. Furthermore, when 
sucrose density gradient centrifugation was performed on 
membranes from C62B cells labeled with 3H-CGP-12177 prior 
to lysis, only the heavy peak receptors were found to be labeled 
(31). Thus,  the receptors with high affinity for agonist de- 
tected with this ligand in intact cells are apparently the 
M. L. Toews, G. L. Waldo, T. K. Harden, and J. P. Perkins, 
manuscript in preparation. 
plasma membrane receptors (which migrate in the heavy 
peak)  and  the receptors that are inaccessible to  this ligand in 
intact cells are those that migrate in the light peak. 
Recent studies with frog erythrocytes suggest that receptor 
internalization may also be involved in desensitization of 
these cells (32-35). Early  studies reported that desensitization 
of these cells was due to loss of @-adrenergic receptors (32). 
More recent studies (34) have shown that in fact these  “lost” 
receptors can be recovered, apparently in a light vesicle frac- 
tion, by high speed centrifugation. These receptors are most 
likely analogous to  the light peak receptors identified in  both 
1321N1 and C62B cells. Further studies of the light vesicle 
receptors from frog erythrocytes led Strulovici et al. (35) to 
conclude that  the receptors in  these vesicles  were fully func- 
tional, and  that  the functional desensitization of these cells 
was due to sequestration of the receptors away from the 
guanine nucleotide binding protein and adenylate cyclase. 
High and low agonist affinity states of the @-adrenergic 
receptor have previously been demonstrated in membrane 
preparations from a variety of sources, including 1321N1 cells 
(19, 36, 37). The high affinity state can be demonstrated only 
in the absence of guanine nucleotides and is believed to 
represent  a  ternary complex between agonist, receptor, and 
the guanine nucleotide binding protein (37, 38). Addition of 
guanine nucleotides to the assays dissociates the guanine 
nucleotide binding protein from this complex and converts all 
of the receptors to  the low affinity  state. In membrane prep- 
arations, desensitized receptors exhibit only low affinity bind- 
ing even in  the absence of guanine nucleotides (26, 34, 40). 
This result  has been interpreted as  an indication that desen- 
sitization causes an “uncoupling” of the @-adrenergic recep- 
tors from the guanine nucleotide binding protein. It would 
seem likely that in the  intact cell there would be sufficient 
guanine nucleotide to prevent accumulation of 6-adrenergic 
receptors in the ternary complex high affinity form. We 
therefore think  it likely that  the  state of the receptor observed 
in  intact cell assays as high affinity  most likely reflects the 
lower affinity state observed in control membrane in the 
presence of guanine nucleotides. 
The KO for isoproterenol binding to @-adrenergic receptors 
in membrane preparations from desensitized 1321N1 cells in 
the presence of guanine nucleotides is in the range of  0.2-0.6 
PM (26), whereas the equilibrium KO for isoproterenol binding 
to  the low affinity receptors in intact cells is in the range of 
8-12 PM (Fig. 2 and Ref. 1). Thus,  the  state of the receptor 
observed as the low affinity form in equilibrium assays in 
intact desensitized cells is apparently  not detected in mem- 
brane  preparations from these cells. This could indicate that 
the modification of the receptor that is responsible for the 
low equilibrium affinity in intact cells is unstable to the 
conditions used to lyse cells and prepare membrane fractions. 
Alternatively, the  apparent low affinity observed at equilib- 
rium in intact cells could be an artifact due to intracellular 
metabolism of agonist or to differential  partitioning of agonist 
into  the extracellular, intracellular, and intravesicular com- 
partments,  and  thus might not  represent any change at all in 
the molecular properties of the receptor, as suggested by 
Strulovici et al. (35). In addition, we should point out that 
due to  the variety of rapid, agonist concentration-dependent 
changes in receptor number, distribution, and ligand proper- 
ties that can occur in intact cells during the course of an 
equilibrium competition binding assay with agonists, it may 
not be possible to ever truly achieve equilibrium or even a 
true steady state of binding in intact cell assays. Thus, it may 
be inappropriate to  interpret  the  apparent affinity observed 
in such assays as being due to simple competition by the 
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agonist for binding to  the  intact cell receptor. In fact, because 
of the above consideration, short time  assays such as those 
used in our studies may be much more appropriate than 
conventional equilibrium assays for investigating the agonist 
binding  properties of @-adrenergic receptors on intact cells. 
To summarize, the studies  reported here describe an ago- 
nist-induced change in  the agonist binding properties of p- 
adrenergic receptors  on intact cells that seems clearly related 
to the overall process of agonist-induced receptor-specific 
desensitization. The properties of the altered form of the 
receptor are entirely consistent with the hypothesis that  it 
results from internalization of a  portion of the cell surface 
receptors. The  nature  and significance of the  apparent low 
affinity for agonists observed in equilibrium assays with intact 
cells and  the relationship to  this phenomenon of the agonist- 
induced changes  reported here remains unknown. 
Acknowledgments-We wish to thank Dr. T. K. Harden for nu- 
merous helpful discussions throughout the course of this work, Drs. 
R. N. Pittman  and P. B. Molinoff for sharing unpublished results, 
and Sherry E. Jones for her expert technical assistance. 
REFERENCES 
1. Toews, M. L., Harden, T. K., and Perkins, J. P. (1983) Proc. 
Natl. Acad. Sci. U. S. A. 80,3553-3557 
2. Perkins, J. P.,  Harden, T. K., and Harper, J. F. (1982) in Hand- 
book of Experimental Pharmacology (Nathanson, J. A., and 
Kebabian, J. W., eds) pp. 185-224, Springer-Verlag, Berlin 
3. Harden, T. K. (1983) Pharmacol. Reu. 35, 5-32 
4. Lefkowitz, R. J., Wessels, M. R., and Stadel, J. M. (1980) Curr. 
Top. Cell. Regul. 17,205-230 
5. Insel, P. A., and Stoolman, L. M. (1978) Mol. Pharmacol. 14 ,  
549-561 
6. Terasaki, W. L., and Brooker, G. (1978) J. Biol. Chem. 2 5 3 ,  
5418-5425 
7. Barovsky, K., and Brooker, G. (1980) J. Cyclic Nucleotide Res. 6 ,  
297-307 
8. Pittman, R. N., and Molinoff, P. B. (1980) J.  Cyclic Nucleotide 
Res. 6,421-435 
9. Shimizu, H., Daly, J. W., and Creveling, C. R. (1969) J.  Neuro- 
chem. 1 6 ,  1609-1619 
10. Su, Y.-F., Johnson, G. L., Cubeddu-Ximenez, L., Leichtling, €3. 
H., Ortmann, R., and Perkins, J. P. (1976) J.  Cyclic Nucleotide 
14. Ehlert, F. J., Roeske, W. R., and Yamamura, H. I. (1981) Mol. 
15. SAS Institute SAS Users’ Guide:Statistics (1977) pp. 317-329, 
16. De Lean, A., Stadel, J. M., and Lefkowitz, R. J .  (1980) J. Biol. 
17. DeLean, A., Hancock, A. A., and Lefkowitz, R. J. (1982) Mol. 
18. Reynolds, E. E., Hoyer, D. R., and Molinoff, P. B. (1982) SOC. 
19. Su, Y.-F., Harden, T. K., and Perkins, J. P. (1980) J .  Biol. Chem. 
20. Terasaki, W. L., Brooker, G., De Vellis, J., Inglish, D., Hsu, C.- 
Y.,  and Moylan, R.  D. (1978) Adu. Cyclic Nucleotide Res. 9,33- 
52 
21. Woods, P. B., and Robinson, M. L. (1981) J.  Pharm. Pharmacol. 
33,172-173 
22. Dax, E. M., and Partilla, J. S. (1982) Mol. Pharmacol. 22,5-7 
23. Mahan, L. C., Koachman, A. M., Motulsky, H. J., and Insel, P. 
A. (1983) Fed. Proc. 42 ,  1875 (abstr.) 
24. Terasaki, W. L., Linden, J., and Brooker, G. (1979) Proc. Natl. 
Acad. Sci. U. S. A. 76 ,  6401-6405 
25. Homburger, V., Lucas, M., Cantau, B., Barabe, J., Penit, J., and 
Bockaert, J. (1980) J.  Biol. Chem. 256 ,  10436-10444 
26. Harden, T. K., Cotton, C. U., Waldo, G. L., Lutton, J .  K., and 
Perkins, J. P. (1980) Science (Wash. D. C.) 210,441-443 
27. Frederich, R. C., Waldo, G .  L., Harden, T. K., and Perkins, J. P. 
(1983) J.  Cyclic Nucleotide Res. 9 ,  103-118 
28. Waldo, G. L., Northup, J. K., Perkins, J. P., and Harden, T. K. 
(1983) J. Biol. Chem. 258, 13900-13908 
29. Staehelin, M., and Simons, P. (1982) Eur. Mol. Biol. Org. J. 1, 
30. Staehelin, M., Simons, P., Jaeggi, K., and Wigger, N. (1983) J.  
31. Hertel, C., Staehelin, M., and Perkins, J. P. (1983) J. Cyclic 
32. Mukhejee, C., Caron, M. G., and Lefkowitz, R. J. (1975) Proc. 
33. Chuang, D. M., and Costa, E. (1979) Proc. Natl. Acad. Sci. U. S. 
34. Stadel, J. M., Strulovici, B., Nambi, P., Lavin, T. N., Briggs, M. 
M., Caron, M. G., and Lefkowitz, R. J. (1983) J. BWZ. Chem. 
35. Strulovici, B., Stadel, J. M., and Lefkowitz,  R. J. (1983) J. Biol. 
36. Maguire, M. E., Van Arsdale, P. M., and Gilman, A. G. (1976) 
37. Lefkowitz, R. J., Mullikin, D., and Caron, M. G. (1976) J.  Biol. 
Pharmacol. 19,367-371 
SAS Institute, Inc., Cary, NC 
Chem. 255,7108-7117 
Pharrnacol. 2 1 ,  5-16 
Neurosci. Abstr. 8 ,  658 
255,7410-7419 
187-190 
Biol. Chem. 258,3496-3502 
Nucleotide Res. 9, 119-128 




Mol. Pharmacol. 12,335-339 
Chem. 251.4686-4692 
Res. 2,271-285 38. Kent, R.  D., DeLean, A., and Lefkowitz, R. J. (1980) Mol. Phar- 
Pharrnacol. 2 1,570-580 39. De Lean, A., Stadel, J. M., and Lefkowitz,  R. J. (1980) J.  Biol. 
11. Harden, T. K., Scheer, A. G., and  Smith, M. M. (1982) Mol. macol. 17,  14-23 
12. Salomon, Y., Londos, C., and Rodbell, M. (1974) Anal. Biochem. Chem. 255,7108-7117 
13. Aranyi, P. (1980) Biochim. Biophys. Acta 628,220-227 Nucleotide Res. 5,99-106 
58,541-548 40. Harden, T. K., Su, Y.-F., and Perkins, J .  P. (1979) J. Cyclic 
